GlassScriptPhysician profile
Krista M Lowe
NPI 1407481930
$2,699.30
in general payments reported to CMS, 2019-2025
27 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $844 · 2022: $497 · 2023: $357 · 2024: $529 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $677.92 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $331.80 | 2021-2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.94 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $193.34 | 2022-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $144.94 | 2022-2024 | Bexsero, Trelegy Ellipta, Pediarix |
| Merck Sharp & Dohme LLC | $140.56 | 2021-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Exact Sciences Corporation | $135.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $133.14 | 2021-2025 | |
| Ironshore Pharmaceuticals INC. | $125.36 | 2024 | |
| Sanofi-Aventis U.S. LLC | $87.02 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $61.14 | 2022-2023 | Rexulti |
| Xeris Pharmaceuticals, INC. | $61.11 | 2021 | |
| Dexcom, INC. | $51.15 | 2024-2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $38.28 | 2022-2023 | |
| Pfizer INC. | $37.74 | 2021-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $37.00 | 2025 | Jornay Pm |
| Boston Scientific Corporation | $33.28 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Janssen Pharmaceuticals, INC | $33.13 | 2021 | |
| Philips North America LLC | $28.98 | 2025 | Extended Holter |
| Corcept Therapeutics | $26.99 | 2025 | Korlym |
| Verrica Pharmaceuticals INC. | $23.48 | 2024 | Ycanth |
| Inspire Medical Systems, INC. | $22.86 | 2024 | Inspire |
| Eisai INC. | $20.15 | 2021 | |
| Corium, LLC | $17.77 | 2022 | |
| Amgen INC. | $15.05 | 2025 | Krystexxa |
| Biohaven Pharmaceuticals, INC. | $14.56 | 2021 | |
| Exeltis, USA INC. | $12.86 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.